Development of an immunomagnetic bead-based time-resolved fluorescence immunoassay for rapid determination of levels of carcinoembryonic antigen in human serum.

A novel immunoassay for the determination of tumor markers in human serum was established by combining a time-resolved fluoroimmunoassay (TRFIA) and immunomagnetic separation. Based on a sandwich-type immunoassay format, analytes in samples were captured by magnetic beads coated with one monoclonal antibody and "sandwiched" by another monoclonal antibody labeled with europium chelates. The immunocomplex was separated and washed by exposure to a magnetic field and treatment with enhancement solution; fluorescence was then measured according to the number of europium ions dissociated. Levels of the model analyte, carcinoembryonic antigen (CEA), were determined in a linear range (1-1000 ng mL(-1)) with a limit of detection of 0.5 ng mL(-1) under optimal conditions. The reproducibility, recovery, and specificity of the immunoassay were demonstrated to be acceptable. To evaluate this novel assay for clinical applications, 239 serum samples were evaluated. Compared with the conventional TRFIA and chemiluminescence immunoassay (CLIA), the correlation coefficients of the developed immunoassay were 0.985 and 0.975, respectively. These results showed good correlation and confirmed that our method is feasible and could be used for the clinical determination of CEA (or other tumor antigens) in human serum.

[1]  A. Gadducci,et al.  Serum tumor markers in the management of ovarian, endometrial and cervical cancer. , 2004, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[2]  J. Sheinfeld,et al.  Tumor marker levels in post-chemotherapy cystic masses: clinical implications for patients with germ cell tumors. , 2004, Journal of Urology.

[3]  L. D. Ciana,et al.  Highly sensitive amperometric enzyme immunoassay for α-fetoprotein in human serum , 1996 .

[4]  P. de Paepe,et al.  Carcinoembryonic antigen elevation in agnogenic myeloid metaplasia , 2000, British journal of haematology.

[5]  A. Gadducci,et al.  The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: a review of the literature. , 2008, Critical reviews in oncology/hematology.

[6]  Peng Liu,et al.  Immunomagnetic bead-based cell concentration microdevice for dilute pathogen detection , 2008, Biomedical microdevices.

[7]  H. Ju,et al.  Noncompetitive enzyme immunoassay for carcinoembryonic antigen by flow injection chemiluminescence. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[8]  J. Fielding,et al.  Demonstration of carcinoembryonic antigen (CEA) expression in normal, chronically inflamed, and malignant pancreatic tissue by immunohistochemistry. , 1986, Journal of clinical pathology.

[9]  H. Kimura,et al.  Simultaneous determination of alpha-fetoprotein and carcinoembryonic antigen in human serum by time-resolved fluoroimmunoassay. , 1999, Analytical biochemistry.

[10]  S. Touloupidis,et al.  Serum CYFRA 21-1 in patients with invasive bladder cancer and its relevance as a tumor marker during chemotherapy. , 2005, The Journal of urology.

[11]  A. Le Cesne,et al.  Ca125 and neuron-specific enolase (NSE) as tumour markers for intra-abdominal desmoplastic small round-cell tumours. , 1997, British Journal of Cancer.

[12]  S. Blacksell,et al.  Development and evaluation of a rapid immunomagnetic bead assay for the detection of classical swine fever virus antigen , 2009, Tropical Animal Health and Production.

[13]  C. Ching,et al.  Enzyme-linked PNA lectin binding assay compared with CA19-9 and CEA radioimmunoassay as a diagnostic blood test for pancreatic cancer. , 1989, British Journal of Cancer.

[14]  S. Nordling,et al.  Tumour-associated trypsin inhibitor (TATI) in human ovarian cyst fluid. Comparison with CA 125 and CEA. , 1987, British Journal of Cancer.

[15]  K. Pettersson,et al.  Monoclonal antibody-based dual-label time-resolved fluorometric assays in a simplified one-step format. , 1996, Clinical chemistry.

[16]  A. Tsuji,et al.  Simultaneous determination of alpha-fetoprotein, human chorionic gonadotropin and estriol in serum of pregnant women by time-resolved fluoroimmunoassay. , 1999, Journal of pharmaceutical and biomedical analysis.

[17]  D. Hunter,et al.  Rapid and Sensitive Detection of Mycobacterium avium subsp. paratuberculosis in Bovine Milk and Feces by a Combination of Immunomagnetic Bead Separation-Conventional PCR and Real-Time PCR , 2004, Journal of Clinical Microbiology.

[18]  D. Bahler,et al.  Immunomagnetic bead separation of mononuclear cells from contaminating granulocytes in cryopreserved blood samples. , 2009, Cryobiology.

[19]  S. Kamiya,et al.  Detection of Helicobacter pylori in Fecal Samples of Gnotobiotic Mice Infected with H. pylori by an Immunomagnetic-Bead Separation Technique , 1998, Journal of Clinical Microbiology.

[20]  Fei Huang,et al.  Magnetically assisted DNA assays: high selectivity using conjugated polymers for amplified fluorescent transduction , 2005, Nucleic acids research.

[21]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[22]  K. Mealy,et al.  Tumour marker detection in oesophageal carcinoma. , 1996, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[23]  T. Whiteside,et al.  Inhibition of apoptosis in human tumour cells by the tumour-associated serpin, SCC antigen-1 , 2000, British Journal of Cancer.

[24]  C. Haglund.  Tumour marker antigen CA 125 in pancreatic cancer : A comparison with CA 19-9 and CEA , 2007 .

[25]  T. M. Chu,et al.  Demonstration of Carcinoembryonic Antigen in Normal Human Plasma , 1972, Nature.

[26]  C. Haglund,et al.  The prognostic value of preoperative serum levels of CA 19-9 and CEA in patients with pancreatic cancer. , 1994, British Journal of Cancer.

[27]  C. Haglund,et al.  Comparison of CA-50, a new tumour marker, with carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in patients with gastrointestinal diseases. , 1987, British Journal of Cancer.

[28]  Z. Bandi,et al.  Highly sensitive qualitative methods for serum choriogonadotropin (hCG): clinical specificity studies. , 1987, Clinical chemistry.

[29]  Xiaoyan Yang,et al.  Luminol/antibody labeled gold nanoparticles for chemiluminescence immunoassay of carcinoembryonic antigen. , 2010, Analytica chimica acta.

[30]  S. Neubauer,et al.  Magnetic Resonance Imaging of Endothelial Adhesion Molecules in Mouse Atherosclerosis Using Dual-Targeted Microparticles of Iron Oxide , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[31]  Richard A. Durst,et al.  Development of an Immunomagnetic Bead-Immunoliposome Fluorescence Assay for Rapid Detection of Escherichia coli O157:H7 in Aqueous Samples and Comparison of the Assay with a Standard Microbiological Method , 2005, Applied and Environmental Microbiology.

[32]  G. Banfi,et al.  Behavior of tumor markers CA19.9, CA195, CAM43, CA242, and TPS in the diagnosis and follow-up of pancreatic cancer. , 1993, Clinical chemistry.

[33]  Manfred Schmitt,et al.  Tumor Markers , 2003, Molecular & Cellular Proteomics.

[34]  Ke Wang,et al.  A novel and sensitive method for the detection of deoxynivalenol in food by time-resolved fluoroimmunoassay , 2009, Toxicology mechanisms and methods.

[35]  E. Bertoft,et al.  Determination of hormones by time-resolved fluoroimmunoassay. , 1984, Talanta.

[36]  Shulin Zhao,et al.  Noncompetitive immunoassay for carcinoembryonic antigen in human serum by microchip electrophoresis for cancer diagnosis. , 2010, Clinica chimica acta; international journal of clinical chemistry.

[37]  Z. Loewy,et al.  COBAS AMPLICOR: fully automated RNA and DNA amplification and detection system for routine diagnostic PCR. , 1996, Clinical chemistry.

[38]  E. Mitchell,et al.  Carcinoembryonic Antigen in the Staging and Follow-up of Patients with Colorectal Cancer , 2005, Cancer investigation.

[39]  Wei-Wen Xu,et al.  Determination of median levels of the free β subunit of human chorionic gonadotropin in women from mainland China using a new time-resolved fluoroimmunoassay , 2010, Clinical chemistry and laboratory medicine.

[40]  Greg L Perkins,et al.  Serum tumor markers. , 2003, American family physician.

[41]  Y. Ashihara,et al.  Rapid and sensitive chemiluminescent enzyme immunoassay for measuring tumor markers. , 1991, Clinical chemistry.

[42]  M. Seemann,et al.  An evaluation of the tumour markers, carcinoembryonic antigen (CEA), cytokeratin marker (CYFRA 21-1) and neuron-specific enolase (NSE) in the differentiation of malignant from benign solitary pulmonary lesions. , 1999, Lung cancer.

[43]  N. Brünner,et al.  Tumor Tissue Concentrations of the Proteinase Inhibitors Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) and Plasminogen Activator Inhibitor Type 1 (PAI-1) Are Complementary in Determining Prognosis in Primary Breast Cancer * , 2003, Molecular & Cellular Proteomics.